Literature DB >> 29686003

Blood Pressure Management: Beyond the Guidelines.

Daniel W Jones1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29686003      PMCID： PMC5945297          DOI： 10.1161/HYPERTENSIONAHA.118.11036

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  10 in total

1.  Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg.

Authors:  Gabriel S Tajeu; John N Booth; Lisandro D Colantonio; Rebecca F Gottesman; George Howard; Daniel T Lackland; Emily C O'Brien; Suzanne Oparil; Joseph Ravenell; Monika M Safford; Samantha R Seals; Daichi Shimbo; Steven Shea; Tanya M Spruill; Rikki M Tanner; Paul Muntner
Journal:  Circulation       Date:  2017-06-20       Impact factor: 29.690

Review 2.  Translating research into practice for healthcare providers: the American Heart Association's strategy for building healthier lives, free of cardiovascular diseases and stroke.

Authors:  Daniel W Jones; Eric D Peterson; Robert O Bonow; Frederick A Masoudi; Gregg C Fonarow; Sidney C Smith; Penelope Solis; Meighan Girgus; Patricia C Hinton; Anne Leonard; Raymond J Gibbons
Journal:  Circulation       Date:  2008-07-14       Impact factor: 29.690

Review 3.  Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis.

Authors:  Xiaoli Chen; Youfa Wang
Journal:  Circulation       Date:  2008-06-16       Impact factor: 29.690

4.  Does blood pressure inevitably rise with age?: longitudinal evidence among forager-horticulturalists.

Authors:  Michael Gurven; Aaron D Blackwell; Daniel Eid Rodríguez; Jonathan Stieglitz; Hillard Kaplan
Journal:  Hypertension       Date:  2012-05-21       Impact factor: 10.190

5.  TROPHY study: Outcomes based on the Seventh Report of the Joint National Committee on Hypertension definition of hypertension.

Authors:  Stevo Julius; Niko Kaciroti; Brent M Egan; Shawna Nesbitt; Eric L Michelson
Journal:  J Am Soc Hypertens       Date:  2008 Jan-Feb

6.  Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis.

Authors:  Joshua D Bundy; Changwei Li; Patrick Stuchlik; Xiaoqing Bu; Tanika N Kelly; Katherine T Mills; Hua He; Jing Chen; Paul K Whelton; Jiang He
Journal:  JAMA Cardiol       Date:  2017-07-01       Impact factor: 14.676

7.  The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group.

Authors:  P K Whelton; J Buring; N O Borhani; J D Cohen; N Cook; J A Cutler; J E Kiley; L H Kuller; S Satterfield; F M Sacks
Journal:  Ann Epidemiol       Date:  1995-03       Impact factor: 3.797

Review 8.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 9.897

9.  Predicting all-cause mortality from basic physiology in the Framingham Heart Study.

Authors:  William B Zhang; Zachary Pincus
Journal:  Aging Cell       Date:  2015-10-08       Impact factor: 9.304

10.  Effectiveness of Chlorthalidone Plus Amiloride for the Prevention of Hypertension: The PREVER-Prevention Randomized Clinical Trial.

Authors:  Sandra Costa Fuchs; Carlos E Poli-de-Figueiredo; José A Figueiredo Neto; Luiz César N Scala; Paul K Whelton; Francisca Mosele; Renato Bandeira de Mello; José F Vilela-Martin; Leila B Moreira; Hilton Chaves; Marco Mota Gomes; Marcos R de Sousa; Ricardo Pereira E Silva; Iran Castro; Evandro José Cesarino; Paulo Cesar Jardim; João Guilherme Alves; André Avelino Steffens; Andréa Araujo Brandão; Fernanda M Consolim-Colombo; Paulo Ricardo de Alencastro; Abrahão Afiune Neto; Antônio C Nóbrega; Roberto Silva Franco; Dario C Sobral Filho; Alexandro Bordignon; Fernando Nobre; Rosane Schlatter; Miguel Gus; Felipe C Fuchs; Otávio Berwanger; Flávio D Fuchs
Journal:  J Am Heart Assoc       Date:  2016-12-13       Impact factor: 5.501
  10 in total
  3 in total

1.  Fumarase Overexpression Abolishes Hypertension Attributable to endothelial NO synthase Haploinsufficiency in Dahl Salt-Sensitive Rats.

Authors:  Hong Xue; Aron M Geurts; Kristie Usa; Feng Wang; Yingying Lin; Jenifer Phillips; Lisa Henderson; Maria Angeles Baker; Zhongmin Tian; Mingyu Liang
Journal:  Hypertension       Date:  2019-06-24       Impact factor: 10.190

2.  Population-Attributable Risk for Cardiovascular Disease Associated With Hypertension in Black Adults.

Authors:  Donald Clark; Lisandro D Colantonio; Yuan-I Min; Michael E Hall; Hong Zhao; Robert J Mentz; Daichi Shimbo; Gbenga Ogedegbe; George Howard; Emily B Levitan; Daniel W Jones; Adolfo Correa; Paul Muntner
Journal:  JAMA Cardiol       Date:  2019-12-01       Impact factor: 14.676

3.  Attenuating the Variability of Lipids Is Beneficial for the Hypertension Management to Reduce the Cardiovascular Morbidity and Mortality in Older Adults.

Authors:  Yuanli Dong; Xukui Liu; Yingxin Zhao; Qiang Chai; Hua Zhang; Yumei Gao; Zhendong Liu
Journal:  Front Cardiovasc Med       Date:  2021-06-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.